. Apolipoprotein B as a New Link Between Cholesterol and Alzheimer Disease. JAMA Neurol. 2019 Jul 1;76(7):751-753. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. It makes a lot of sense to look at early onset cases for potential genetic associations because early onset is clearly more strongly “genetic.” If we better understood how these variants work mechanistically, we might be able to design prevention or treatment.

    It’s good that Wingo and colleagues were able to assemble so many EOAD cases, however, I have some concerns about their choice of controls and how different the controls were from the cases they assembled. ApoE and ApoB variants likely have associations with survival and, of course, a lot of people as they age are being treated with lipid-lowering drugs which would affect that relationship. There may be a lot more to be learned about this association in my judgment.

    View all comments by Eric Larson

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Is APOB a Risk Gene for Early Onset Alzheimer’s?